Legal Representation
Attorney
Susan Piascik Christoff
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jul 9, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 9, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jul 9, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 24, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 24, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 24, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 21, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 21, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 13, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Sep 13, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines; medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use
Class 042
Scientific research and development services in the fields of pharmaceuticals, medicine, vaccines, biologics, biotherapeutics, biosimilars and therapeutics; vaccine development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals, medicine, vaccines, biologics, biotherapeutics, biosimilars and therapeutics; clinical research services; providing medical and scientific research information about the results of clinical trials for pharmaceuticals, medicine, vaccines, biologics, biotherapeutics, biosimilars and therapeutics; scientific research for medical purposes; research and development services of technology in the fields of pharmaceuticals, medicine, vaccines, biologics, biotherapeutics, biosimilars and therapeutics; providing scientific research information in the fields of pharmaceuticals, medicine, vaccines, biologics, biotherapeutics, biosimilars, therapeutics and health science
Additional Information
Design Mark
The mark consists of the letter "V" inside a broken circle to the left of the words VACCINE COMPANY, where VACCINE is above COMPANY.
Design Mark
The mark consists of the letter "V" inside a broken circle to the left of the words VACCINE COMPANY, where VACCINE is above COMPANY.
Color Claim
Color is not claimed as a feature of the mark.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
VACCINE VACCINE COMPANY
Pseudo Mark
VACCINE VACCINE COMPANY
Classification
International Classes
005
042